Tag: left atrial appendage

US FDA grants Investigational Device Exemption to Aegis Medical for Sierra...

Aegis Medical Innovations has received Investigational Device Exemption approval from the US FDA to initiate a clinical trial in the US for its Sierra...

Occlutech left atrial appendage occluder shows high procedural success in first-in-man...

The first-in-man study exploring the safety, feasibility and neurological outcome with the Occlutech left atrial appendage (LAA) occluder (Occlutech) has shown a 93% procedural...

First Texas centre uses St Jude Medical Amplatzer Amulet

The Texas Cardiac Arrhythmia Institute at St David's Medical Center,  Austin, USA became the first facility in the US state of Texas to implant...

Amulet study shows high implant success rates with Amplatzer Amulet LAA...

A study presented at the last late-breaking trial session of the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October-2 November, Washington, DC, USA) indicates...

CE mark granted to Occlutech left atrial appendage occluder

Occlutech has obtained European CE mark approval for its left atrial appendage, (LAA), occluder. The device is a specifically designed implant for the minimally...